Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment()

BACKGROUND: Ipilimumab (IPI) and BRAF inhibitors (BRAFi) improve survival in melanoma, but not all patients will benefit and toxicity can be significant. Pretreatment neutrophil to lymphocyte ratio (NLR) has been associated with outcome in IPI-treated patients, but has not been studied during treatm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EBioMedicine
Main Authors: Cassidy, Michael R., Wolchok, Rachel E., Zheng, Junting, Panageas, Katherine S., Wolchok, Jedd D., Coit, Daniel, Postow, Michael A., Ariyan, Charlotte
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5405176/
https://ncbi.nlm.nih.gov/pubmed/28356222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2017.03.029
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados